Skip to content


Cerebyx, Sesquient (fosphenytoin) is a small molecule pharmaceutical. Fosphenytoin was first approved as Cerebyx on 1996-08-05. It is used to treat epilepsy, seizures, and status epilepticus in the USA. Fosphenytoin sodium's patent is valid until 2033-02-27 (FDA).
Trade Name Cerebyx, Sesquient
Common Name Fosphenytoin
Indication epilepsy, seizures, status epilepticus
Drug Class Antiepileptics (hydantoin derivatives); phosphoro-derivatives
Get full access now